Cargando…

Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium Eenhancement

Detalles Bibliográficos
Autores principales:	Soslow, Jonathan H, Damon, Stephen M, Crum, Kimberly, Parra, David, Arai, Andrew E, Damon, Bruce M, Markham, Larry W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032297/ http://dx.doi.org/10.1186/1532-429X-18-S1-P279

Ejemplares similares

Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy
por: Soslow, Jonathan H., et al.
Publicado: (2016)

T1 mapping is abnormal before decline in EF in patients with Becker and Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2013)

Left ventricular function by echocardiography correlates poorly with cardiac MRI measures in Duchenne muscular dystrophy
por: Soslow, Jonathan H, et al.
Publicado: (2014)

Myocardial strain imaging in Duchenne muscular dystrophy
por: Earl, Conner C., et al.
Publicado: (2022)

Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
por: Raucci, Frank J., et al.
Publicado: (2021)

Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy
por: Arteaga, David, et al.
Publicado: (2020)

Duchenne Muscular Dystrophy Patients: Troponin Leak in Asymptomatic and Implications for Drug Toxicity Studies
por: Sheybani, Aryaz, et al.
Publicado: (2022)

Patterns of late gadolinium enhancement in Duchenne muscular dystrophy carriers
por: Giglio, Vincenzo, et al.
Publicado: (2014)

Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers
por: Wexberg, Paul, et al.
Publicado: (2016)

Increased Number of Circulating CD8/CD26 T Cells in the Blood of Duchenne Muscular Dystrophy Patients Is Associated with Augmented Binding of Adenosine Deaminase and Higher Muscular Strength Scores
por: Soslow, Jonathan H., et al.
Publicado: (2017)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
por: Ganigara, Madhusudan, et al.
Publicado: (2016)

Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne Muscular Dystrophy
por: Galindo, Cristi L., et al.
Publicado: (2015)

Regional 4D Cardiac Magnetic Resonance Strain Predicts Cardiomyopathy Progression in Duchenne Muscular Dystrophy
por: Earl, Conner C., et al.
Publicado: (2023)

Presence of late gadolinium enhancement in Duchenne muscular dystrophy patients is associated with age and global ventricular function
por: Hor, Kan N, et al.
Publicado: (2012)

Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy
por: Sunthankar, Sudeep D., et al.
Publicado: (2023)

Serial assessment of myocardial T2 in Duchenne muscular dystrophy
por: Wansapura, Janaka, et al.
Publicado: (2011)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy
por: Lee, Tae Ho, et al.
Publicado: (2014)

Elevated myocardial extracellular volume fraction in Duchenne muscular dystrophy
por: Starc, James, et al.
Publicado: (2016)

Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
por: REZAEI TAVIRANI, Mostafa, et al.
Publicado: (2017)

Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function
por: Hor, Kan N, et al.
Publicado: (2013)

Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance
por: Earl, Conner C., et al.
Publicado: (2023)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
por: Farini, Andrea, et al.
Publicado: (2020)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ak3jhspm6lg32nba2hitc5jgs8